Skip to main content

Perspectives

The Era of Personalized Medicine in Oncology: Novel Biomarkers Ushering in New Approaches to Cancer Therapy

Steve Stricker, PharmD, MS, BCOP

Moving Beyond Medicare’s ACOs to Accountable Care

Murali Karamchedu, Sam Muppalla, Robert Capobianco

Clinical, Perspectives

Modeling Costs and Outcomes Associated with a Treatment Algorithm for Problem Bleeding Episodes in Patients with Severe Hemophilia A and High-Titer Inhibitors

Patrick Bonnet, PharmD, Alessandro Gringeri, MD, Edward Gomperts, MD, Cindy Anne Leissinger, MD, Roseline d’Oiron, MD, Jerome Teitel, MD, Guy Young, MD, Meg Franklin, PharmD, PhD, Bruce Ewenstein, MD, Erik Berntorp, MD, PhD

Stakeholder Perspective

Potential Cost-Savings Using a Treatment Algorithm for Problem Bleeding Episodes in Patients with Hemophilia and Inhibitors

by Hetty A. Lima, RPh, FASHP

Systematic Health Management: The Time Has Come to Do the Right Thing for Each Person

Jeff Rideout, MD, MA, FACP

Regulatory, Perspectives

Comparative Effectiveness Research in the United States: A Catalyst for Innovation

Riaz Ali, MPP, Morgan Hanger, MPP, Tanisha Carino, PhD

Five Steps Healthcare Leaders Can Take to Address Childhood Obesity

Jennifer Lovejoy, PhD

Regulatory, Perspectives

Implications of the New Political Realities on Healthcare Reform

FDA Approvals, Perspectives

Wayne Kuznar, Nirav R. Shah, MD,MPH, F. Randy Vogenberg, PhD, FASHP

No, You Can't Keep Your Health Plan: Insurers and Doctors Are Already Consolidating Their Businesses in the Wake of ObamaCare's Passage

Scott Gottlieb, MD

What Is Happening to the Pipeline?

1
2
3
4
5

Page 4 of 5
Results 31 - 40 of 48